Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Landry Benjamin, General Counsel at Health Catalyst , Inc. (NASDAQ:HCAT), recently sold 13,827 shares of the company’s common stock. The transaction, executed on March 6, 2025, was made at an average price of $4.5462 per share, amounting to a total value of approximately $62,860. The sale comes as the stock trades near its 52-week low of $3.76, with the current share price at $3.97. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value metrics. Following this sale, Benjamin retains ownership of 160,437 shares in the company. The sale was conducted under a pre-established trading plan adopted on March 1, 2024, in compliance with Rule 10b5-1. The transaction occurs amid challenging market conditions for Health Catalyst, with the stock down over 45% in the past six months. For deeper insights into HCAT’s valuation and 9 additional key investment tips, visit InvestingPro, where you’ll find comprehensive analysis in the Pro Research Report.
In other recent news, Health Catalyst Inc. reported its financial results for the fourth quarter of 2024, with revenue at $79.6 million, slightly missing the forecast of $80.68 million. The company experienced a notable earnings miss, posting an EPS of -$0.33 against a forecast of $0.07. Despite these setbacks, Health Catalyst saw a 6% year-over-year increase in revenue and a significant 485% increase in adjusted EBITDA to $7.9 million for the quarter. For the full year, total revenue reached $370 million, marking a 4% growth, while adjusted EBITDA surged by 137% to $26 million.
BTIG analysts responded by lowering the price target for Health Catalyst shares from $13 to $10, while maintaining a Buy rating. The company reaffirmed its 2025 revenue guidance at approximately $335 million, slightly below the consensus estimate, and raised its EBITDA guidance to about $41 million. Health Catalyst is transitioning from lower-margin Technology-Enabled Management Services (TEMS) agreements, which is anticipated to improve margins over time. The company also highlighted its strategic shift to the Ignite platform, which is expected to enhance its technology revenue growth by 13% in 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.